Leader in single-cell and spatial biology tools (Chromium, Visium, Xenium) used to dissect tumours.
10x Genomics, based in Pleasanton, California, and listed as TXG, is the leader in single-cell and spatial biology tools, with Chromium for single-cell RNA and ATAC sequencing, Visium HD for spatial transcriptomics and Xenium for in situ analysis. Its instruments are core to tumour microenvironment research and to the atlases from which cell-state models are built. OnCo links it to single-cell and spatial profiling and spatial biology instruments, to bottlenecks on cold tumours and tumour heterogeneity, and to ideas such as mapping which tumour clones sit next to which immune cells before choosing therapy and setting standards for spatial biomarkers before they reach the clinic. Whether spatial biology moves from research tool to clinical test is the open question. The technology pages carry the detail.
Shares Spatial-omics-guided treatment selection, Turn the map of immune cells inside a tumour into a standardised test.
Shares Spatial transcriptomics platforms (Visium HD, Xenium, MERFISH, CosMx, CODEX), Spatial biology instruments, Single-cell & spatial profiling.
Shares Single-cell RNA sequencing (scRNA-seq, 10x Chromium), Single-cell & spatial profiling, Cold tumours and the immunosuppressive microenvironment.
Shares Single-cell & spatial profiling, Tumour heterogeneity and clonal evolution.
Shares Single-cell & spatial profiling, Tumour heterogeneity and clonal evolution.
Shares Single-cell & spatial profiling, Cold tumours and the immunosuppressive microenvironment.
Shares Map which tumour clones sit next to which immune cells before choosing therapy, Standards for spatial and multiplex tissue biomarkers before they reach the clinic, Spatial-omics-guided treatment selection, Turn the map of immune cells inside a tumour into a standardised test.
Shares Single-cell & spatial profiling, Cold tumours and the immunosuppressive microenvironment.